Lower your risk, increase your value.   Smart up your business and work with              !
Luc Villeneuve, PhD, CEO
Who We Are
Our Services
Customer Satisfaction

October 22, 2019


Immuni T is proud to announce that we have been recognized by the Standards Council of Canada (SCC) as being compliant with the OECD Principles of Good Laboratory Practice (GLP). GLP regulates the conduct of all non-clinical safety studies worldwide; the SCC is the only monitoring body that grants GLP recognition in Canada.

GLP recognition means that Immuni T has the infrastructure, personnel, and knowledge to conduct studies that produce valid and high quality data intended for submission to Health Canada, the US FDA, and regulatory bodies around the world (IND or CTA). In the drug development process, these bodies use this data to decide whether clinical studies in humans can proceed.

Immuni T develops, validates, and executes GLP-compliant toxicity, anti-drug antibody (ADA), and other assays, to support non-clinical safety studies.

Immuni T is a Montreal-based contract research organization (CRO) that offers immunology services on flow cytometry, ligand binding, and cell-based platforms.

To learn more about Immuni T's GLP services, contact us at or +1-514-545-3097 extension 102.

November 07, 2018

Is Your Biotherapeutic Immunomodulatory? How to Use Immunoassays to Get the Right Answer

Topics covered in this webinar were:

  • Why assessment of immune-based therapies’ mechanism of action is pivotal to their further application

  • About the physiological relevance of ex vivo immuno-modulation assays and appropriate data interpretation

  • How having better knowledge of the immune characteristics of the drug at an early stage of development will save time and money and will allow better preclinical and clinical desig

October 09, 2018

Farideh Nourian, Ph.D Joins ImmuniT's Team

Immuni T proudly announces the appointment of Dr. Farideh Nourian as the new member of board of directors. Dr. Nourian will serve as Director of Business Development and brings a wealth of experience and expertise that were gained from twenty years of working as assistant professor in academia and Principal Scientist at CRO, Biotech and Pharmaceutical companies in North America such as Kiadis Pharma, Charles River Laboratories (CRL) and Algorithme Pharma. Most recently, Dr. Nourian has been involved in a string of successful consulting for Pliant Pharmaceutics in USA.


Dr. Nourian holds B.Sc and M.Sc in Biology and Medical Microbiology, respectively and obtained her Ph.D in Biotechnology/Food Science from McGill University. She has two post-doctoral training in the fields of cell and molecular biology at McGill University and Microbiology at Agriculture and Agri-Food Canada.


Immuni T is pleased that she accepted this appointment and know she will represent the company well and will contribute much to its success.

1 / 5

Please reload


CRO services

BeLPT samples


5th floor, suite SB-5180

141 President-Kennedy Avenue , 

Montréal, Québec, Canada H2X-1Y4

P.O.BOX #3

Telephone : +1(514) 545 3097

Fax : +1(514) 545 3064



Telephone : +1(514) 545 3097 

Fax : +1(514) 545 3064

Email :